José Thomas

7.0k total citations
77 papers, 4.3k citations indexed

About

José Thomas is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, José Thomas has authored 77 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Pathology and Forensic Medicine, 28 papers in Pulmonary and Respiratory Medicine and 25 papers in Genetics. Recurrent topics in José Thomas's work include Lymphoma Diagnosis and Treatment (57 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Lung Cancer Treatments and Mutations (20 papers). José Thomas is often cited by papers focused on Lymphoma Diagnosis and Treatment (57 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Lung Cancer Treatments and Mutations (20 papers). José Thomas collaborates with scholars based in Belgium, Netherlands and France. José Thomas's co-authors include Patrice Carde, Peter Vandenberghe, Sigrid Stroobants, Karoline Spaepen, Gregor Verhoef, Patrick Dupont, M. Henry‐Amar, Jan Balzarini, Hanneke C. Kluin‐Nelemans and Iwona Włodarska and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

José Thomas

77 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
José Thomas Belgium 38 3.3k 1.5k 1.2k 1.2k 1.1k 77 4.3k
Beate Pfistner Germany 16 4.3k 1.3× 2.5k 1.7× 965 0.8× 1.6k 1.3× 1.1k 1.0× 43 5.1k
Luigi Rigacci Italy 28 3.1k 1.0× 1.6k 1.0× 798 0.6× 974 0.8× 809 0.8× 144 4.0k
B Coiffier France 18 3.7k 1.1× 2.4k 1.6× 564 0.5× 1.0k 0.8× 1.4k 1.3× 43 4.4k
Christophe Fermé France 26 3.7k 1.1× 2.4k 1.6× 617 0.5× 1.3k 1.1× 1.2k 1.2× 98 4.3k
Carol S. Portlock United States 38 4.2k 1.3× 2.7k 1.8× 966 0.8× 1.4k 1.1× 1.5k 1.4× 119 5.6k
G. Vaughan Hudson United Kingdom 33 3.1k 1.0× 2.0k 1.3× 915 0.7× 896 0.7× 893 0.8× 66 4.0k
G P Canellos United States 23 2.1k 0.7× 1.2k 0.8× 728 0.6× 806 0.7× 515 0.5× 33 2.8k
Andreas Josting Germany 33 2.8k 0.9× 1.7k 1.1× 931 0.8× 1.2k 1.0× 776 0.7× 95 3.6k
Jehan Dupuis France 32 3.1k 1.0× 1.8k 1.2× 617 0.5× 729 0.6× 926 0.9× 115 4.1k
Lars Møller Pedersen Denmark 28 2.1k 0.6× 1.4k 0.9× 586 0.5× 564 0.5× 972 0.9× 103 3.4k

Countries citing papers authored by José Thomas

Since Specialization
Citations

This map shows the geographic impact of José Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Thomas more than expected).

Fields of papers citing papers by José Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Thomas. The network helps show where José Thomas may publish in the future.

Co-authorship network of co-authors of José Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of José Thomas. A scholar is included among the top collaborators of José Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Thomas. José Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, José, et al.. (2013). Nitrofurantoin related pulmonary disease: a clinical reminder. BMJ Case Reports. 2013. bcr2013009299–bcr2013009299. 7 indexed citations
2.
Kaaij, Marleen A. E. van der, Natacha Heutte, Jannie van Echten‐Arends, et al.. (2009). Sperm quality before treatment in patients with early stage Hodgkin's lymphoma enrolled in EORTC-GELA Lymphoma Group trials. Haematologica. 94(12). 1691–1697. 49 indexed citations
3.
Eisen, Tim, José Thomas, Wilson H. Miller, et al.. (2009). Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma. Melanoma Research. 19(3). 185–192. 28 indexed citations
4.
Brepoels, Lieselot, Sigrid Stroobants, Walter De Wever, et al.. (2008). Positron emission tomography in mantle cell lymphoma. Leukemia & lymphoma. 49(9). 1693–1701. 39 indexed citations
5.
Brepoels, Lieselot, Sigrid Stroobants, Walter De Wever, et al.. (2007). Aggressive and indolent non-Hodgkin's lymphoma: Response assessment by Integrated International Workshop Criteria. Leukemia & lymphoma. 48(8). 1522–1530. 29 indexed citations
6.
Brepoels, Lieselot, Sigrid Stroobants, Walter De Wever, et al.. (2007). Hodgkin lymphoma: Response assessment by Revised International Workshop Criteria. Leukemia & lymphoma. 48(8). 1539–1547. 47 indexed citations
7.
Noordijk, Evert M., Patrice Carde, N. Dupouy, et al.. (2006). Combined-Modality Therapy for Clinical Stage I or II Hodgkin's Lymphoma: Long-Term Results of the European Organisation for Research and Treatment of Cancer H7 Randomized Controlled Trials. Journal of Clinical Oncology. 24(19). 3128–3135. 149 indexed citations
8.
Spaepen, Karoline, Sigrid Stroobants, Patrick Dupont, et al.. (2002). Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin’s lymphoma. Annals of Oncology. 13(9). 1356–1363. 317 indexed citations
9.
Aleman, Berthe M.P., M. Henry‐Amar, Umberto Tirelli, et al.. (2001). Involved field irradiation (IFRT) does not improve outcome in patients with stage III/IV Hodgkin's lymphoma (HL) in complete remission after MOPP/ABV (M/A): Results of the randomised EORTC trial 20884. Blood. 98(11). 6 indexed citations
10.
Dierlamm, Judith, Carla Rosenberg, Michel Stul, et al.. (1997). Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization. Leukemia. 11(5). 747–758. 104 indexed citations
11.
Dierlamm, Judith, Carla Rosenberg, Michel Stul, et al.. (1996). Chromosomal gains and losses in marginal zone B-cell lymphoma detected by comparative genomic hybridization. Blood. 1 indexed citations
12.
Stroobants, Sigrid, Patrick Dupont, Gregor Verhoef, et al.. (1996). Comparison of whole-body positron emission tomography and Gallium-67 citrate imaging for staging of lymphoma. Blood. 88(10). 901–901. 2 indexed citations
13.
Blondeel, Phillip, et al.. (1995). Primary leiomyosarcoma of the diaphragm. European Journal of Surgical Oncology. 21(4). 429–431. 6 indexed citations
14.
15.
Bodis, Stephan, M. Henry‐Amar, J. Bosq, et al.. (1993). Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer protocols.. Journal of Clinical Oncology. 11(2). 225–232. 42 indexed citations
16.
Cosset, Jean‐Marc, M. Henry‐Amar, J.H. Meerwaldt, et al.. (1992). The EORTC trials for limited stage Hodgkin's disease. European Journal of Cancer. 28(11). 1847–1850. 47 indexed citations
17.
Thomas, José, Ben de Pauw, Anton Hagenbeek, et al.. (1992). Phase II study of cytarabine in Hodgkin's disease. European Journal of Cancer. 28(4-5). 857–859. 3 indexed citations
18.
Wolf‐Peeters, Chris De, José Thomas, Iwona Wlodarska, et al.. (1991). Chromosome 1p Abnormalities in B Non Hodgkin's Lymphoma. Leukemia & lymphoma. 5(2-3). 193–199. 2 indexed citations
19.
Henry‐Amar, M., M. Hayat, J.H. Meerwaldt, et al.. (1990). Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. International Journal of Radiation Oncology*Biology*Physics. 19(5). 1155–1157. 80 indexed citations
20.
Hier, Daniel B., et al.. (1989). Predictors of Survival in Clinically Diagnosed Alzheimer's Disease and Multi-Infarct Dementia. Archives of Neurology. 46(11). 1213–1216. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beate Pfistner Breakdown of academic impact, for papers by Luigi Rigacci Breakdown of academic impact, for papers by B Coiffier Breakdown of academic impact, for papers by Christophe Fermé Breakdown of academic impact, for papers by Carol S. Portlock Breakdown of academic impact, for papers by G. Vaughan Hudson Breakdown of academic impact, for papers by G P Canellos Breakdown of academic impact, for papers by Andreas Josting Breakdown of academic impact, for papers by Jehan Dupuis Breakdown of academic impact, for papers by Lars Møller Pedersen
Rankless by CCL
2026